Genetic determinants of the response to bezafibrate treatment in the lower extremity arterial disease event reduction (LEADER) trial.
Atherosclerosis 2002 Jul 163 (1): 183-92.
Jamshidi Y, Flavell D M, Hawe E, MacCallum P K, Meade T W, Humphries S
- Page last reviewed:Mar 1, 2018
- Page last updated:Jul 11, 2019
- Content source: